18889881171
Kalkine 0
countryflagUS

AAPL 196.98 1.395% MSFT 367.78 -1.0307% NVDA 101.49 -2.8711% GOOGL 151.16 -1.4152% GOOG 153.36 -1.3762% AMZN 172.61 -0.9866% META 501.48 -0.1652% AVGO 170.99 -2.0732% LLY 839.96 14.2958% TSLA 241.37 -0.0745% TSM 151.74 0.0462% V 329.61 -0.5191% JPM 231.96 1.0235% UNH 454.11 -22.3797% NVO 58.08 -7.6336% WMT 93.22 2.2261% LVMUY 110.1 1.0741% XOM 106.92 2.6202% LVMHF 559.0 1.7288% MA 517.33 0.7596%

Digital Development Partners Inc

Healthcare US BBBT

0.0001USD
-(-%)

Last update at 2025-04-17T13:30:00Z

Day Range

0.00010.0001
LowHigh

52 Week Range

-0.0002
LowHigh

Fundamentals

  • Previous Close 0.0001
  • Market Cap0.18M
  • Volume0
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-0.02602M
  • Revenue TTM0.04M
  • Revenue Per Share TTM-
  • Gross Profit TTM -0.00626M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -1.65877M -1.81130M -0.12197M -0.12197M -0.12111M
Minority interest - - - - -
Net income -2.02920M -2.09663M -0.16363M -0.12197M -0.12111M
Selling general administrative 1.00M 1.36M 0.08M 0.08M 0.08M
Selling and marketing expenses 0.23M 0.00523M 0.00192M - -
Gross profit 0.03M 0.02M 0.03M - -
Reconciled depreciation 0.09M 0.11M - - -
Ebit -1.28833M -1.45113M -0.68480M -0.14967M -0.00055M
Ebitda -1.19926M -1.34147M -0.08031M -0.08031M -0.08354M
Depreciation and amortization 0.09M 0.11M 0.00498M - -
Non operating income net other - - - - -
Operating income -1.28833M -1.45113M -0.08031M -0.08031M -0.08354M
Other operating expenses 1.37M 1.56M 0.08M - 0.08M
Interest expense 0.37M 0.29M 0.04M 0.04M 0.04M
Tax provision 0.00000M 0.00000M 0.00000M - -
Interest income - - - - -
Net interest income -0.37059M -0.28533M -0.00587M -0.04166M -0.03757M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.37M 0.29M 0.04M - -
Total revenue 0.08M 0.10M 0.06M 0.00000M 0.00000M
Total operating expenses 1.32M 1.47M 0.08M 0.08M 0.08M
Cost of revenue 0.05M 0.08M 0.03M - -
Total other income expense net -0.37043M -0.36018M -0.04166M - -0.03757M
Discontinued operations - - - - -
Net income from continuing ops -1.65877M -1.81130M -0.69016M -0.12197M -0.12111M
Net income applicable to common shares -1.65877M -1.81130M -0.69016M -0.14937M -0.00055M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 0.22M 0.77M 0.00097M 0.00097M 0.00473M
Intangible assets 0.08M 0.08M - - -
Earning assets - - - - -
Other current assets 0.04M 0.10M 0.01M - -
Total liab 0.87M 0.10M 1.14M 1.14M 1.02M
Total stockholder equity -0.65017M 0.67M -1.14080M -1.14080M -1.01883M
Deferred long term liab 0.08M - - - -
Other current liab 0.10M 0.00969M 0.26M - 0.23M
Common stock 0.31M 0.30M 0.09M 0.09M 0.09M
Capital stock 0.31M 0.30M 0.16M 0.09M 0.09M
Retained earnings -4.27995M -2.62118M -8.71571M -8.71571M -8.59375M
Other liab - - - - -
Good will - - - - -
Other assets 0.08M - 0.02M - -
Cash 0.04M 0.50M 0.00097M 0.00097M 0.00473M
Cash and equivalents - - - - -
Total current liabilities 0.87M 0.10M 1.14M 1.14M 1.02M
Current deferred revenue - - - - -
Net debt 0.63M -0.44143M 0.87M 0.87M 0.79M
Short term debt 0.67M 0.06M 0.87M - 0.79M
Short long term debt 0.67M 0.06M 0.05M 0.87M 0.79M
Short long term debt total 0.67M 0.06M 0.87M - 0.79M
Other stockholder equity 3.32M 2.99M 7.49M - 7.49M
Property plant equipment 0.00713M 0.01M - - -
Total current assets 0.14M 0.68M 0.00097M 0.00097M 0.00473M
Long term investments - - - - -
Net tangible assets - 0.59M 0.03M -1.14080M 0.04M
Short term investments - - - - -
Net receivables 0.00226M 0.00274M - - -
Long term debt - - - - -
Inventory 0.09M 0.07M 0.04M - -
Accounts payable 0.10M 0.04M 0.00867M 0.27M -
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other -0.00815M - 0.02M - -
Deferred long term asset charges - - - - -
Non current assets total 0.08M 0.10M 0.02M 0.00000M 0.00000M
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments 0.00000M -0.18570M -0.02000M - -
Change to liabilities 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Total cashflows from investing activities - -0.18570M -0.02000M -0.02000M -0.02000M
Net borrowings 0.58M -0.08623M 0.08M 0.18M 0.18M
Total cash from financing activities 0.58M 1.62M 0.08M 0.18M 0.08M
Change to operating activities 0.08M -0.00543M 0.06M -0.01573M -0.01573M
Net income -1.65877M -1.81130M -0.12197M -0.14937M -0.12111M
Change in cash -0.45532M 0.45M -0.00376M 0.05M 0.00316M
Begin period cash flow 0.50M 0.05M 0.00473M 0.00473M 0.00157M
End period cash flow 0.04M 0.50M 0.00097M 0.00097M 0.00473M
Total cash from operating activities -1.03257M -0.99243M -0.08632M -0.13114M -0.07610M
Issuance of capital stock 0.00000M 1.71M 0.53M - -
Depreciation 0.09M 0.11M 0.11M 0.11M 0.11M
Other cashflows from investing activities - -0.18000M -0.02000M -0.02000M -0.02000M
Dividends paid - 0.00000M 0.00000M - -
Change to inventory -0.01392M -0.03479M -0.03021M -0.00658M -0.00658M
Change to account receivables 0.00048M -0.00274M -0.00274M -0.00892M -0.00892M
Sale purchase of stock - - - - -
Other cashflows from financing activities 1.02M 0.83M 0.22M -0.00800M 0.08M
Change to netincome 0.19M 0.49M 0.04M 0.05M 0.05M
Capital expenditures 0.00000M 0.00570M 0.00570M 0.00570M 0.00570M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.17M -0.13064M 0.04M 0.04M 0.05M
Stock based compensation - - - - -
Other non cash items 0.37M 0.84M 0.06M - -
Free cash flow -1.03257M -0.99813M -0.08632M -0.08632M -0.07610M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
BBBT
Digital Development Partners Inc		 - -% 0.0001 - - 4.92 3.53 25.35 -36.0964
ZTS
Zoetis Inc		 1.91 1.30% 148.67 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR		 -0.27 1.01% 26.51 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 -5.72 4.21% 130.21 21.73 14.95 3.16 2.15 3.56 12.82
TAK
Takeda Pharmaceutical Co Ltd ADR		 0.06 0.41% 14.71 32.67 11.53 0.01 0.87 0.02 0.07

Reports Covered

Stock Research & News

View All

Profile

Black Bird Biotech Inc. provides various biotech products. It manufactures and distributes MiteXstream, a plant-based biopesticide for the eradication of spider mites. The company also manufactures and sells CBD Oils, gummies and pet treats, CBD-infused personal care products, and hand sanitizer under the Grizzly Creek Naturals brand name. In addition, it grows industrial hemp under the Montana Hemp pilot program. The company was formerly known as Digital Development Partners, Inc. and changed its name to Black Bird Biotech, Inc. in June 2021. Black Bird Biotech, Inc. is based in Argyle, Texas.

Digital Development Partners Inc

11961 Hilltop Road, Argyle, TX, United States, 76226

Key Executives

Name Title Year Born
Mr. Fabian G. Deneault Chairman & Pres 1967
Mr. William E. Sluss CFO, VP of Fin. & Director 1955
Mr. Eric Newlan Jr. VP, Sec. & Director 1962
Mr. William J. LoBell Exec. VP of Sales & Devel. 1948
Mr. Fabian G. Deneault Chairman of the Board & President 1967
Mr. William E. Sluss CFO, VP of Finance & Director 1955
Mr. Eric Newlan Esq. VP, Secretary & Director 1962
Mr. Nelson Grist Chief Executive Officer NA
Mr. William J. LoBell Executive Vice President of Sales & Development 1948

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.